Stocks
Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -3.47 | -2.06 | -0.69 | -14.3 | 1 403 | 222.1 | |
| Changes by years, y/y, % | -35% | -41% | -66% | +1 960% | -9 914% | |||
Arcutis Biotherapeutics. EV/EBITDA
Arcutis Biotherapeutics. EV/EBITDA, changes, %
Arcutis Biotherapeutics (ARQT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -18.6 | -24.8 | -97.2 | 1 333 | 222.1 | 222.1 | |
| Changes by years, y/y, % | +277% | +309% | +1 436% | -9 422% | -1 292% | |||
| Changes by quarters, q/q, % | +30% | +33% | +292% | -1 471% | -83% | |||
